Semler Scientific, Inc. (NASDAQ:SMLR – Get Free Report) saw some unusual options trading activity on Tuesday. Stock investors purchased 6,648 call options on the company. This is an increase of 289% compared to the typical volume of 1,709 call options.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen downgraded Semler Scientific from a “buy” rating to a “sell” rating in a research note on Thursday, May 22nd.
Read Our Latest Analysis on SMLR
Institutional Trading of Semler Scientific
Semler Scientific Stock Down 7.3%
SMLR opened at $31.50 on Wednesday. Semler Scientific has a 52 week low of $21.77 and a 52 week high of $81.56. The firm has a market cap of $351.29 million, a P/E ratio of 6.42 and a beta of 1.42. The business’s fifty day simple moving average is $35.72 and its 200 day simple moving average is $46.07.
Semler Scientific (NASDAQ:SMLR – Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The company had revenue of $8.84 million during the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.
Semler Scientific Company Profile
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
See Also
- Five stocks we like better than Semler Scientific
- Insider Trades May Not Tell You What You Think
- AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway
- How to Plot Fibonacci Price Inflection Levels
- Casey’s Surges on Strong Q4, More Gains Likely Ahead
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Government Mandate Sends eVTOL Stocks Flying
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.